<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">17185803</PMID>
        <DateCompleted>
            <Year>2007</Year>
            <Month>02</Month>
            <Day>20</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1355-008X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>30</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2006</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Endocrine</Title>
                <ISOAbbreviation>Endocrine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia: a case report and a review of the literature.</ArticleTitle>
            <Pagination>
                <MedlinePgn>145-9</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Carbohydrate intolerance is a common feature of acromegaly. Frank diabetes mellitus is seen in about 10-20% of patients. There is no report of acromegaly presenting with diabetic ketoacidosis (DKA), associated with retinitis pigmentosa (RP), in the literature. We report the occurrence of DKA and RP in a patient with acromegaly. A 39-year-old Turkish man was admitted to the emergency ward with a 1-mo history of thirst, polyuria, weight loss of 10 kg, and loss of consciousness for 2 d. Physical examination revealed findings suggestive of acromegaly, including coarse facial features and enlargement of his hands and feet. At ophthalmological examination, funduscopy showed RP. Laboratory studies confirmed the diagnoses of DKA and acromegaly. Magnetic resonance imaging disclosed the presence of a pituitary adenoma. During the medical treatment with octreotide, symptomatic sinusoidal bradycardia was developed (pulse rate 45 bpm, and blood pressure 70/40 mmHg). Octreotide therapy was stopped. Pituitary adenoma was removed surgically. For treatment of DKA, insulin need was very high in the first days after the onset of ketoacidosis, but decreased after initiation of treatment with octreotide and after successful operation. Insulin was stopped 7 d after surgery. Follow-up showed normalization of growth hormone levels and plasma glucose levels. Only six other cases of DKA associated with acromegaly and only three other cases of RP associated with acromegaly were found in the medical literature. In conclusion, to our knowledge, the present case is a first report of DKA and RP in patient with acromegaly.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Erem</LastName>
                    <ForeName>Cihangir</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Endocrinology and Metabolism, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey. cihangirerem@netscape.net</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ersöz</LastName>
                    <ForeName>Halil Onder</ForeName>
                    <Initials>HO</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ukinç</LastName>
                    <ForeName>Kubilay</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Avunduk</LastName>
                    <ForeName>Avni Murat</ForeName>
                    <Initials>AM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hacihasanoglu</LastName>
                    <ForeName>Arif</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koçak</LastName>
                    <ForeName>Mustafa</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Endocrine</MedlineTA>
            <NlmUniqueID>9434444</NlmUniqueID>
            <ISSNLinking>1355-008X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>RWM8CCW8GP</RegistryNumber>
                <NameOfSubstance UI="D015282">Octreotide</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000172" MajorTopicYN="N">Acromegaly</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000236" MajorTopicYN="N">Adenoma</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001919" MajorTopicYN="N">Bradycardia</DescriptorName>
                <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016883" MajorTopicYN="N">Diabetic Ketoacidosis</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D049912" MajorTopicYN="N">Growth Hormone-Secreting Pituitary Adenoma</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015282" MajorTopicYN="N">Octreotide</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012174" MajorTopicYN="N">Retinitis Pigmentosa</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2006</Year>
                <Month>06</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2006</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2006</Year>
                <Month>07</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2006</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2007</Year>
                <Month>2</Month>
                <Day>21</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2006</Year>
                <Month>12</Month>
                <Day>23</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">17185803</ArticleId>
            <ArticleId IdType="pii">ENDO:30:1:145</ArticleId>
            <ArticleId IdType="doi">10.1385/ENDO:30:1:145</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Postgrad Med J. 1996 Nov;72(853):682-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8944212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocr Pract. 2004 May-Jun;10(3):213-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15382339</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br Heart J. 1985 Feb;53(2):153-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2857086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Endocrinol Invest. 1996 Oct;19(9):647-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8957752</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Pract. 1997 Oct;51(7):476-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9536592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Sci Monit. 2001 Jan-Feb;7(1):142-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11208511</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1990 Aug 4;336(8710):318-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1974009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pharm. 1989 Apr;8(4):255-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2653711</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Liver. 1995 Oct;15(5):236-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8531592</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Endocrinol Metab. 1997 Oct;82(10):3308-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9329359</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Intern Med. 1997 May;36(5):345-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9213172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacotherapy. 1998 Mar-Apr;18(2):413-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9545165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Endocrinol Invest. 1993 Dec;16(11):857-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8144862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hepatology. 1995 May;21(5):1255-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7737631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Braz J Med Biol Res. 2001 Nov;34(11):1429-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11668352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Ophthalmol. 1972 Jan;56(1):25-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5058713</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Doc Ophthalmol. 1999;98(2):175-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10947002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anesth Analg. 2004 Feb;98(2):318-20, table of contents</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14742361</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cardiovasc Res. 2001 Jan;49(1):27-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11121793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocr Rev. 2004 Feb;25(1):102-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14769829</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocr J. 1995 Dec;42(6):739-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8822314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocr Pract. 2000 Nov-Dec;6(6):450-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11155217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Care. 1979 May-Jun;2(3):296-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">116831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Endocrinol (Oxf). 1987 Apr;26(4):481-512</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3308190</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>